Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenofovir DF versus emtricitabine + tenofovir DF in chronic hepatitis B with persistent viral replication during adefovir treatment
2005-003136-22Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tenofovir disoproxil fumarate, emtricitabine + tenofovir disoproxil in Chronic Hepatitis B (CHB), sponsored by Gilead Sciences. Started Dec 2005; status: completed.
02
Drugs
tenofovir disoproxil fumarateemtricitabine + tenofovir disoproxil
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on 2005-003136-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003136-22.